Carlson Capital’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-500,096
| Closed | -$12.2M | – | 274 |
|
|
2019
Q1 | $12.2M | Sell |
500,096
-483,464
| -49% | -$11.8M | 0.22% | 145 |
|
|
2018
Q4 | $25.5M | Buy |
983,560
+433,310
| +79% | +$11.2M | 0.4% | 69 |
|
|
2018
Q3 | $17.4M | Buy |
550,250
+325,250
| +145% | +$10.3M | 0.22% | 124 |
|
|
2018
Q2 | $8.74M | Sell |
225,000
-120,730
| -35% | -$4.69M | 0.12% | 184 |
|
|
2018
Q1 | $9.54M | Sell |
345,730
-1,155,814
| -77% | -$31.9M | 0.14% | 173 |
|
|
2017
Q4 | $27.2M | Sell |
1,501,544
-471,391
| -24% | -$8.53M | 0.46% | 62 |
|
|
2017
Q3 | $31.9M | Sell |
1,972,935
-121,860
| -6% | -$1.97M | 0.55% | 48 |
|
|
2017
Q2 | $29M | Sell |
2,094,795
-106,365
| -5% | -$1.47M | 0.41% | 76 |
|
|
2017
Q1 | $33M | Buy |
+2,201,160
| New | +$33M | 0.42% | 75 |
|